vs

Side-by-side financial comparison of GULF ISLAND FABRICATION INC (GIFI) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

GULF ISLAND FABRICATION INC is the larger business by last-quarter revenue ($51.5M vs $35.5M, roughly 1.5× RECURSION PHARMACEUTICALS, INC.). GULF ISLAND FABRICATION INC runs the higher net margin — 3.0% vs -304.2%, a 307.3% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 36.9%). GULF ISLAND FABRICATION INC produced more free cash flow last quarter ($2.7M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs 7.6%).

Gulf Island Fabrication is an American manufacturer of specialized structures and marine vessels used in the energy sector. it owns seven building yards in Louisiana and Texas and has Bechtel as a partner.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

GIFI vs RXRX — Head-to-Head

Bigger by revenue
GIFI
GIFI
1.5× larger
GIFI
$51.5M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+644.8% gap
RXRX
681.7%
36.9%
GIFI
Higher net margin
GIFI
GIFI
307.3% more per $
GIFI
3.0%
-304.2%
RXRX
More free cash flow
GIFI
GIFI
$50.0M more FCF
GIFI
$2.7M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
7.6%
GIFI

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GIFI
GIFI
RXRX
RXRX
Revenue
$51.5M
$35.5M
Net Profit
$1.6M
$-108.1M
Gross Margin
9.5%
59.8%
Operating Margin
2.2%
-304.8%
Net Margin
3.0%
-304.2%
Revenue YoY
36.9%
681.7%
Net Profit YoY
-32.7%
39.6%
EPS (diluted)
$0.10
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GIFI
GIFI
RXRX
RXRX
Q4 25
$35.5M
Q3 25
$51.5M
$5.2M
Q2 25
$37.5M
$19.2M
Q1 25
$40.3M
$14.7M
Q4 24
$37.4M
$4.5M
Q3 24
$37.6M
$26.1M
Q2 24
$41.3M
$14.4M
Q1 24
$42.9M
$13.8M
Net Profit
GIFI
GIFI
RXRX
RXRX
Q4 25
$-108.1M
Q3 25
$1.6M
$-162.3M
Q2 25
$-574.0K
$-171.9M
Q1 25
$3.8M
$-202.5M
Q4 24
$4.3M
$-178.9M
Q3 24
$2.3M
$-95.8M
Q2 24
$1.9M
$-97.5M
Q1 24
$6.2M
$-91.4M
Gross Margin
GIFI
GIFI
RXRX
RXRX
Q4 25
59.8%
Q3 25
9.5%
-183.8%
Q2 25
9.5%
-4.9%
Q1 25
16.4%
-48.0%
Q4 24
19.6%
-181.4%
Q3 24
12.4%
53.7%
Q2 24
10.1%
36.2%
Q1 24
14.3%
19.1%
Operating Margin
GIFI
GIFI
RXRX
RXRX
Q4 25
-304.8%
Q3 25
2.2%
-3327.6%
Q2 25
-2.9%
-916.8%
Q1 25
8.1%
-1297.9%
Q4 24
9.7%
-4042.4%
Q3 24
4.4%
-377.1%
Q2 24
3.1%
-697.4%
Q1 24
13.3%
-698.4%
Net Margin
GIFI
GIFI
RXRX
RXRX
Q4 25
-304.2%
Q3 25
3.0%
-3135.3%
Q2 25
-1.5%
-894.2%
Q1 25
9.5%
-1373.3%
Q4 24
11.5%
-3935.5%
Q3 24
6.2%
-367.5%
Q2 24
4.6%
-676.6%
Q1 24
14.6%
-662.4%
EPS (diluted)
GIFI
GIFI
RXRX
RXRX
Q4 25
$-0.17
Q3 25
$0.10
$-0.36
Q2 25
$-0.04
$-0.41
Q1 25
$0.23
$-0.50
Q4 24
$0.26
$-0.56
Q3 24
$0.14
$-0.34
Q2 24
$0.11
$-0.40
Q1 24
$0.37
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GIFI
GIFI
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$23.2M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$94.3M
$1.1B
Total Assets
$146.7M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GIFI
GIFI
RXRX
RXRX
Q4 25
$743.3M
Q3 25
$23.2M
$659.8M
Q2 25
$46.8M
$525.1M
Q1 25
$28.6M
$500.5M
Q4 24
$27.3M
$594.4M
Q3 24
$21.3M
$427.6M
Q2 24
$9.5M
$474.3M
Q1 24
$32.5M
$296.3M
Total Debt
GIFI
GIFI
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
GIFI
GIFI
RXRX
RXRX
Q4 25
$1.1B
Q3 25
$94.3M
$1.0B
Q2 25
$92.8M
$919.1M
Q1 25
$96.7M
$933.9M
Q4 24
$93.1M
$1.0B
Q3 24
$88.8M
$524.6M
Q2 24
$86.7M
$584.4M
Q1 24
$85.4M
$401.2M
Total Assets
GIFI
GIFI
RXRX
RXRX
Q4 25
$1.5B
Q3 25
$146.7M
$1.4B
Q2 25
$134.3M
$1.3B
Q1 25
$138.2M
$1.3B
Q4 24
$133.2M
$1.4B
Q3 24
$130.8M
$726.5M
Q2 24
$133.3M
$775.9M
Q1 24
$127.8M
$557.8M
Debt / Equity
GIFI
GIFI
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GIFI
GIFI
RXRX
RXRX
Operating Cash FlowLast quarter
$2.9M
$-46.1M
Free Cash FlowOCF − Capex
$2.7M
$-47.3M
FCF MarginFCF / Revenue
5.2%
-133.1%
Capex IntensityCapex / Revenue
0.4%
3.5%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$8.6M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GIFI
GIFI
RXRX
RXRX
Q4 25
$-46.1M
Q3 25
$2.9M
$-117.4M
Q2 25
$2.5M
$-76.4M
Q1 25
$2.2M
$-132.0M
Q4 24
$2.3M
$-115.4M
Q3 24
$5.6M
$-59.2M
Q2 24
$3.3M
$-82.2M
Q1 24
$7.0M
$-102.3M
Free Cash Flow
GIFI
GIFI
RXRX
RXRX
Q4 25
$-47.3M
Q3 25
$2.7M
$-117.6M
Q2 25
$2.2M
$-79.6M
Q1 25
$1.9M
$-133.8M
Q4 24
$1.8M
$-116.7M
Q3 24
$4.3M
$-63.8M
Q2 24
$2.3M
$-83.4M
Q1 24
$4.5M
$-109.0M
FCF Margin
GIFI
GIFI
RXRX
RXRX
Q4 25
-133.1%
Q3 25
5.2%
-2272.5%
Q2 25
5.9%
-413.9%
Q1 25
4.7%
-907.4%
Q4 24
4.9%
-2567.7%
Q3 24
11.5%
-244.6%
Q2 24
5.5%
-578.5%
Q1 24
10.4%
-789.9%
Capex Intensity
GIFI
GIFI
RXRX
RXRX
Q4 25
3.5%
Q3 25
0.4%
4.7%
Q2 25
0.8%
16.4%
Q1 25
0.8%
12.4%
Q4 24
1.2%
28.6%
Q3 24
3.5%
17.5%
Q2 24
2.5%
8.2%
Q1 24
6.0%
48.2%
Cash Conversion
GIFI
GIFI
RXRX
RXRX
Q4 25
Q3 25
1.83×
Q2 25
Q1 25
0.58×
Q4 24
0.54×
Q3 24
2.44×
Q2 24
1.74×
Q1 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GIFI
GIFI

Fabrication Segment$30.6M59%
Time And Materials And Cost Reimbursable$19.8M38%
Other Basis Of Pricing$1.0M2%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons